YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Novartis makes offer to buy German cancer drugmaker

Posted online

Swiss health care company Novartis has made a tender offer to acquire German cancer drugmaker MorphoSys.

Novartis is offering $73 per share, a premium of around 142%.

Novartis also recently announced it's pausing enrollment of new patients in clinical trials for Kisqali, a breast cancer treatment.

Read more from Quartz.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Open for Business: Evergreen Hair House

Evergreen Hair House opened; the Ozark Chamber of Commerce moved to a new home; and Dirk’s Tavern LLC got its start on C-Street.

Most Read
Update cookies preferences